Medicare Enrolled

Dr. Philip Savia, MD

Optician · Plains, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
670 S RIVER ST STE 203, Plains, PA 18705
5705527110
In practice since 2006 (19 years)
NPI: 1487733564 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Savia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Savia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Savia

Dr. Philip Savia is an optician specialist in Plains, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Savia performed 808 Medicare services across 613 unique beneficiaries.

Between the years covered by Open Payments, Dr. Savia received a total of $46,231 from 29 pharmaceutical and/or device companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Savia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 36% volume in PA $46,231 industry payments

Medicare Practice Summary

Medicare Utilization ↗
808
Medicare services
Top 36% in PA for optician
613
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~43 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
490 $86 $305
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
96 $43 $133
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
66 $127 $413
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
40 $132 $443
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
37 $43 $135
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
37 $79 $263
EEG monitoring for coma or sleep
This procedure measures brain wave activity to monitor patients who are in a coma or asleep.
19 $45 $143
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
12 $107 $394
Nerve conduction study, 3-4 tests
A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function.
11 $82 $329
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$46,231
Total received (2018-2024)
Avg $6,604/year across 7 years
Top 6% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
369
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39,123 (84.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,589 (9.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,519 (5.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,379
2023
$5,811
2022
$4,929
2021
$14,604
2020
$11,594
2019
$4,715
2018
$1,200

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,280
ACADIA Pharmaceuticals Inc
$46
Amgen Inc.
$20
Life Molecular Imaging Ltd
$19
Amneal Pharmaceuticals LLC
$13
Top 3 companies account for 99.0% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$16,111
Allergan, Inc.
$14,756
ABBVIE INC.
$8,128
Amgen Inc.
$3,352
Teva Pharmaceuticals USA, Inc.
$807
EISAI INC.
$465
Supernus Pharmaceuticals, Inc.
$327
Eisai Inc.
$295
Novartis Pharmaceuticals Corporation
$278
Alexion Pharmaceuticals, Inc.
$249
Lilly USA, LLC
$235
Amneal Pharmaceuticals LLC
$225
Adamas Pharmaceuticals, Inc.
$183
ACADIA Pharmaceuticals Inc
$163
Medtronic USA, Inc.
$90
Biohaven Pharmaceuticals, Inc.
$82
LivaNova USA, Inc.
$81
US WorldMeds, LLC
$76
Biogen, Inc.
$71
Avanir Pharmaceuticals, Inc.
$47
Acorda Therapeutics, Inc
$47
Allergan Inc.
$41
Neurocrine Biosciences, Inc.
$24
Braemar Manufacturing, LLC
$22
Life Molecular Imaging Ltd
$19
UCB, Inc.
$19
CATALYST PHARMACEUTICALS, INC.
$17
PFIZER INC.
$11
Medtronic Vascular, Inc.
$11
Top 3 companies account for 84.3% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · APOKYN · AUSTEDO · Aduhelm · Aimovig · BOTOX · BOTOX THERAPEUTIC · Briviact · Cardiac Monitoring Suite · EMGALITY · FIRDAPSE · Fycompa · GOCOVRI · INBRIJA · INGREZZA · LYRICA · NEURACEQ · NUEDEXTA · NUPLAZID · NURTEC ODT · OXTELLAR XR · QULIPTA · RYTARY · Reveal LINQ · SOLIRIS · Soliris · Solitaire · TROKENDI XR · UBRELVY · VNS Therapy · VRAYLAR · Xadago
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for optician in PA.

Looking for an optician specialist in Plains?
Compare opticians in the Plains area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
97
Per 100K population
29.8
County median income
$62,321
Nearest hospital
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
10.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Savia is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Savia experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Savia performed 490 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Savia receive payments from pharmaceutical companies?
Yes. Dr. Savia received a total of $46,231 from 29 companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Savia's costs compare to other opticians in Plains?
Dr. Savia's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Savia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →